Atorvastatin Related Compound C (20 mg) (Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)- 2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt)(CAS: 693793-53-2)
![Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt) Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt)](https://cnstatic.chemtradehub.com/structs/693/693793-53-2-a56b.webp)
CAS号
相关产品
其他供应商提供的 Atorvastatin Related Compound C (20 mg) (Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)- 2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt)
基本信息
分子式
C33H33CaF2N2O5+
分子量
615.7 g/mol
物理状态
White to Off-White
Physical Properties
熔点
>141°C (dec.)
沸点
720.7±60.0 °C at 760 mmHg
密度
1.3±0.1 g/cm3
闪点
389.7±32.9 °C
化学标识符
SMILES
O[C@@H](C[C@H](CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccc(cc1)F)C(=O)Nc1ccccc1.[Ca+2]
InChIKey
BWZBINZLUPJFAN-CNZCJKERSA-M
数据库引用
MDL号
MFCD26142858
常见问题
阿托伐他汀钙杂质C是一种化学物质,其化学名称为(3R,5R)-7-[3-(苯甲酰基)-4,5-双(4-氟苯基)-2-异丙基-1H-吡咯-1-基]-3,5-二羟基庚酸钙盐,分子式为C33H38CaF4N2O7。它是一种在阿托伐他汀钙生产过程中产生的副产物。
阿托伐他汀钙杂质C主要用于药物研究和开发过程中作为参考物质,以评估产品质量和纯度。在药物生产过程中,它通常需要被控制在一定范围内,以确保最终产品的质量。
阿托伐他汀钙杂质C在合理使用和正确储存的情况下是安全的。但在处理时,应避免吸入粉尘或颗粒,避免接触眼睛和皮肤。应佩戴适当的个人防护装备,如手套和防护眼镜。
应将阿托伐他汀钙杂质C存放在干燥、阴凉、避光的地方,避免高温或潮湿环境。建议使用密封、避光的容器储存。储存温度应控制在室温范围内,避免直接阳光照射。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
联系人
汪经理
邮箱
3008058303@qq.com



![2-[(6-Methoxy-1H-benzimidazol-2-yl)methyl]-3,5-dimethyl-4(1H)-pyridinone](https://cnstatic.chemtradehub.com/structs/138/1384163-92-1-9a16.webp)
![N-[(2'-Cyano-4-biphenylyl)methyl]-N-pentanoyl-L-valine](https://cnstatic.chemtradehub.com/structs/443/443093-86-5-91f8.webp)

![3-(6-Chloro-5-fluoropyrimidin-4-YL)-2-(2,4-difluorophenyl)-1-[1,2,4]triazol-1-YL-butan-2-OL](https://cnstatic.chemtradehub.com/structs/137/137234-75-4-eadc.webp)

![1-[[(2E)-3-Phenyl-2-propen-1-yl]oxy]naphthalene](https://cnstatic.chemtradehub.com/structs/109/1091626-77-5-7310.webp)
![5-[(2S)-2-{[2-(2-Ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide](https://cnstatic.chemtradehub.com/structs/106/106138-88-9-ea21.webp)
![Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt) — 深圳摩科生化科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cea6402b2de6e8e95a497f/67cea6402b2de6e8e95a497f-logo.webp)
![Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt) — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)
![Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt) — 北京百灵威科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cde31e57537e5c8069aebf/67cde31e57537e5c8069aebf-logo.webp)
![Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt) — 深圳振强生物技术有限公司](https://cnstatic.chemtradehub.com/suppliers/67cec9142b2de6e8e95a51e7/67cec9142b2de6e8e95a51e7-logo.webp)